At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Taisho Pharmaceutical
- Class Antidementias; Epoxy compounds; Neuroprotectants; Polyenes; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 14 Sep 1998 Discontinued-Preclinical in Neurological disorders in Japan (Unknown route)
- 25 Jul 1996 Preclinical development for Neurological disorders in Japan (Unknown route)
- 24 Jul 1996 New profile